These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30743017)

  • 1. Aripiprazole augmentation in treating comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review.
    Amerio A; Odone A; Ghaemi SN
    J Affect Disord; 2019 Apr; 249():15-19. PubMed ID: 30743017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates in treating comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review.
    Amerio A; Maina G; Ghaemi SN
    J Affect Disord; 2019 Sep; 256():433-440. PubMed ID: 31234022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review.
    Amerio A; Odone A; Marchesi C; Ghaemi SN
    J Affect Disord; 2014 Sep; 166():258-63. PubMed ID: 25012439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole Augmentation to Mood Stabilizers for Obsessive-Compulsive Symptoms in Bipolar Disorder.
    Di Salvo G; Maina G; Pessina E; Teobaldi E; Barbaro F; Martini A; Albert U; Rosso G
    Medicina (Kaunas); 2020 Dec; 57(1):. PubMed ID: 33374357
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological Treatment for Comorbid Bipolar Disorder and Obsessive-Compulsive Disorder in Adults.
    Netto VM; Flores CA; Pallanti S
    J Psychiatr Pract; 2020 Sep; 26(5):383-393. PubMed ID: 32936585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence and predictors of comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review and meta-analysis.
    Amerio A; Stubbs B; Odone A; Tonna M; Marchesi C; Ghaemi SN
    J Affect Disord; 2015 Nov; 186():99-109. PubMed ID: 26233320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole augmentation in managing comorbid obsessive-compulsive disorder and bipolar disorder: a case with suicidal attempts.
    Lai J; Lu Q; Zhang P; Xu T; Xu Y; Hu S
    Neuropsychiatr Dis Treat; 2017; 13():87-90. PubMed ID: 28096676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic validity of comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review.
    Amerio A; Odone A; Liapis CC; Ghaemi SN
    Acta Psychiatr Scand; 2014 May; 129(5):343-58. PubMed ID: 24506190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of obsessive-compulsive disorder on the antimanic response to olanzapine therapy in youth with bipolar disorder.
    Joshi G; Mick E; Wozniak J; Geller D; Park J; Strauss S; Biederman J
    Bipolar Disord; 2010 Mar; 12(2):196-204. PubMed ID: 20402712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Course of illness in comorbid bipolar disorder and obsessive-compulsive disorder patients.
    Amerio A; Tonna M; Odone A; Stubbs B; Ghaemi SN
    Asian J Psychiatr; 2016 Apr; 20():12-4. PubMed ID: 27025465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part I: pharmacological treatment.
    de Oliveira MVS; de Barros PMF; de Mathis MA; Boavista R; Chacon P; Echevarria MAN; Ferrão YA; Vattimo EFQ; Lopes AC; Torres AR; Diniz JB; Fontenelle LF; Rosário MCD; Shavitt RG; Miguel EC; da Silva RMF; Costa DLDC
    Braz J Psychiatry; 2023 May; 45(2):146-161. PubMed ID: 36749887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of comorbid obsessive-compulsive disorder with aripiprazole in three patients with bipolar disorder.
    Uguz F
    Gen Hosp Psychiatry; 2010; 32(5):556-8. PubMed ID: 20851277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bipolar co-morbidity in pediatric obsessive-compulsive disorder: clinical and treatment implications.
    Masi G; Perugi G; Millepiedi S; Toni C; Mucci M; Pfanner C; Berloffa S; Pari C; Akiskal HS
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):475-86. PubMed ID: 17822342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative, single-blind, randomized study on quetiapine and aripiperazole augmentation in treatment of selective serotonin reuptake inhibitor refractory obsessive-compulsive disorder.
    Talaei A; Hosseini FF; Aghili Z; Akhondzadeh S; Asadpour E; Mehramiz NJ; Forouzanfar F
    Can J Physiol Pharmacol; 2020 Apr; 98(4):236-242. PubMed ID: 32228235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of the use of risperidone, paliperidone and aripiprazole as augmenting agents for obsessive-compulsive disorder.
    Brakoulias V; Stockings E
    Expert Opin Pharmacother; 2019 Jan; 20(1):47-53. PubMed ID: 30360669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
    Bloch MH; Landeros-Weisenberger A; Kelmendi B; Coric V; Bracken MB; Leckman JF
    Mol Psychiatry; 2006 Jul; 11(7):622-32. PubMed ID: 16585942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A NATURALISTIC EXPLORATORY STUDY OF OBSESSIVE-COMPULSIVE BIPOLAR COMORBIDITY IN YOUTH.
    Masi G; Berloffa S; Mucci M; Pfanner C; D'Acunto G; Lenzi F; Liboni F; Manfredi A; Milone A
    J Affect Disord; 2018 Apr; 231():21-26. PubMed ID: 29408159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: a randomized double blind placebo controlled clinical trial.
    Sahraian A; Bigdeli M; Ghanizadeh A; Akhondzadeh S
    J Affect Disord; 2014 Sep; 166():201-5. PubMed ID: 25012432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifetime bipolar disorder comorbidity and related clinical characteristics in patients with primary obsessive compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS).
    Dell'Osso B; Vismara M; Benatti B; Cirnigliaro G; Grancini B; Fineberg NA; Van Ameringen M; Hollander E; Stein DJ; Menchon JM; Rodriguez CI; Nicolini H; Lanzagorta N; Pallanti S; Grassi G; Lochner C; Marazziti D; Hranov G; Karamustafalioglu O; Hranov L; Zohar J
    CNS Spectr; 2020 Jun; 25(3):419-425. PubMed ID: 31131775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Recommendations for Augmentation Agents in Obsessive-Compulsive Disorder Partially Responsive to Serotonin Reuptake Inhibitors.
    Gautam M
    J Clin Psychopharmacol; 2023 Jul-Aug 01; 43(4):369-377. PubMed ID: 37335203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.